Verrica Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.60
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.11
|
0.00
|
0.11
|
101.73%
|
|
2022-06-30
|
-0.32
|
-0.37
|
-0.05
|
-15.63%
|
|
2022-03-31
|
-0.47
|
-0.31
|
0.16
|
34.04%
|
|
2021-12-31
|
-0.50
|
-0.35
|
0.15
|
30.00%
|
|
2021-09-30
|
-0.51
|
-0.47
|
0.04
|
7.84%
|
|
2021-06-30
|
-0.41
|
-0.43
|
-0.02
|
-4.88%
|
|
2021-03-31
|
-0.35
|
-0.04
|
0.31
|
88.57%
|
|
2020-12-31
|
-0.42
|
-0.52
|
-0.10
|
-23.81%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.68
|
|
2021-12-31
|
-1.29
|
|
2020-12-31
|
-1.71
|
|
2019-12-31
|
-1.13
|
|
2018-12-31
|
-1.69
|
|
2017-12-31
|
-0.20
|